FIGURE 50-2 Structures and mechanism of nucleoside and nucleotide reverse transcriptase inhibitors.

harbor HIV. Nucleoside and nucleotide analogs must enter cells and undergo phosphorylation to generate synthetic substrates for the enzyme (Figure 50-3). The fully phosphorylated analogs block replication of the viral genome both by competitively inhibiting incorporation of native nucleotide and by terminating elongation of nascent proviral DNA because they lack a 3'-hydroxyl group.

All but one of the drugs in this class is a nucleoside that must be triphosphorylated at the 5'-hydroxyl to exert activity. The sole exception, tenofovir, is a nucleoside monophosphate analog that requires two phosphates for full activity. These compounds inhibit both HIV-1 and HIV-2 and several have broad-spectrum activity against other retroviruses; some are also active against hepatitis B virus (HBV) or the herpesviruses.

Although many of the drugs in this class induce only a modest decrease in HIV RNA when used as monotherapy, several have favorable safety and tolerability profiles that make them a valuable component of combination regimens.

Table 50-2

Pharmacokinetic Properties of Nucleoside and Nucleotide Reverse Transcriptase Inhibitors*










Oral bioavailability, %

Was this article helpful?

0 0
Diabetes 2

Diabetes 2

Diabetes is a disease that affects the way your body uses food. Normally, your body converts sugars, starches and other foods into a form of sugar called glucose. Your body uses glucose for fuel. The cells receive the glucose through the bloodstream. They then use insulin a hormone made by the pancreas to absorb the glucose, convert it into energy, and either use it or store it for later use. Learn more...

Get My Free Ebook

Post a comment